Journal of Cancer Immunology & Therapy

All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.
Journal of Cancer Immunology & Therapy 44 7897 074717

Cancer Future Open Access

Many cancers are fueled by biochemical changes of histones, the proteins that function spools for DNA in our cells (histones are shown in green with their cancer-induced changes in purple).
Although the history of attempts to understand and control cancer is affected by disappointments, many significant advances in research and treatment are made in recent years. Today, we've more reasons than ever to be hopeful. These are five of them.

In addition to drugs like ipilimumab and nivolumab, MSK researchers are developing another immunotherapy strategy during which a patient’s own T cells are manipulated to more readily attack cancer cells. during this treatment, called chimeric antigen receptor therapy, or CAR therapy, T cells are collected from a patient’s blood, genetically engineered to acknowledge certain proteins on cancer cells, and infused back to the patient’s bloodstream.
Cancer may be a group of diseases involving abnormal cell growth with the potential to invade or spread to other parts of the body. These contrast with benign tumors, which don't spread

High Impact List of Articles
Conference Proceedings

Relevant Topics in Immunology & Microbiology

Get the App